- Home
- BZFD vs NRSN Comparison
BZFD vs NRSN Comparison
Compare BZFD & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZFD | NRSN |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | Israel |
| Employees | N/A | 15 |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 28.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BZFD | NRSN |
|---|---|---|
| Price | $0.79 | $0.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 184.7K | 134.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.51 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $292.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.74 | $0.68 |
| 52 Week High | $2.68 | $2.60 |
Technical Indicators
Market Signals| Indicator | BZFD | NRSN |
|---|---|---|
| Relative Strength Index (RSI) | 44.71 | 42.62 |
| Support Level | $0.77 | $0.68 |
| Resistance Level | $0.84 | $1.30 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 57.39 | 9.71 |
Price Performance
Historical ComparisonAbout BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.